Cargando…
Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort
Lipid-lowering drugs are used for the prevention of cardiovascular diseases. Statins are the most commonly used lipid-lowering drugs. Evidence from preclinical and observational studies suggests that statins might improve the prognosis of breast cancer patients. We analyzed data from the German MARI...
Autores principales: | Nickels, Stefan, Vrieling, Alina, Seibold, Petra, Heinz, Judith, Obi, Nadia, Flesch-Janys, Dieter, Chang-Claude, Jenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783471/ https://www.ncbi.nlm.nih.gov/pubmed/24086446 http://dx.doi.org/10.1371/journal.pone.0075088 |
Ejemplares similares
-
Dietary patterns and survival in German postmenopausal breast cancer survivors
por: Vrieling, A, et al.
Publicado: (2013) -
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
por: Vrieling, Alina, et al.
Publicado: (2011) -
Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer?
por: Obi, Nadia, et al.
Publicado: (2011) -
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2011) -
Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer
por: Buck, K, et al.
Publicado: (2011)